Kalos Therapeutics


Published: 2014-07-14 16:47:13


Michael Kozlowski OD, PHD,  Chief Science Officer

Kalos Therapeutics, Inc dedicated to treating patients not just their  diseases. Kalos is a peptide therapeutic company treating virulent cancers and the related comorbidities. The Kalos solution focuses in putting tumor cells into a prolonged non dividing state, also treating the ascites and edema that lead to pain and death. Kalos drugs engage known pathway receptors in the MAPK pathway and it does so more efficiently without the side effects associated with chemotherapeutic compounds. As confirmed in an Investigator IND our clinical effects of increased natriuresis and diuresis will treat the related comorbidities of cancer reducing ascites, and edema, as well as shrinking the tumor.

Categories: Events & Education
Sign in or Create an account to comment!